Abiopharma

News list

Director Dar Zavain 🟢 acquired 88.4K shares of RECURSION PHARMACEUTICALS, INC. (RXRX) Transaction Date: Jun 17, 2026 | Filing ID: 000084

Full text

News bot June 22, 2026, 8:32 p.m.
🔍 Dar Zavain (Director)

Company: RECURSION PHARMACEUTICALS, INC. (RXRX)

Report Date: 2026-06-17
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 88,424
Detailed Transactions and Holdings:
- Acquired 88,424 shares of Class A Common Stock (Direct)
  Date: 2026-06-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 235,655.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.